News

---

 We’re excited to share that Prodessa will be attending AHNTI 2026 in Boston! We look forward to connecting with fellow innovators, researchers, and industry leaders who share our vision of advancing animal health and tackling pet obesity.

A healthier tomorrow for our companions today. 🐾

More information on the conference can be found here: https://ahnti-us.com/events/ahnti-us

Following an inspiring and highly productive NLS Days 2026, the team at Prodessa Pharmaceuticals would like to extend our sincere gratitude to the organizers and everyone who took the time to connect with us during the event.

This NLS Days was particularly special for Prodessa, as we also celebrated our first anniversary — marking one year since the company was founded and the beginning of an exciting journey toward transforming weight management for companion animals.

The event provided a valuable platform to connect with the Nordic life science community, exchange ideas, and share our vision for developing innovative solutions in veterinary medicine. We are grateful for the inspiring conversations, valuable insights, and new connections that continue to strengthen our journey. As we look ahead to the next chapter, we are excited to build on the momentum of our first year and continue advancing our pipeline and our mission to improve the health and wellbeing of companion animals.

We would like to thank everyone who has been part of our journey so far. We look forward to continuing to build meaningful partnerships and collaborations as Prodessa enters its second year.

Missed us at NLS Days? We would still love to connect. Visit our contact page or follow our corporate LinkedIn page to get in touch.

We are excited to announce that Prodessa Pharmaceuticals has been selected to present a poster at NLSDays Innovation Poster Session 2026 in Stockholm, Sweden (8-9 September). 

This event brings together top industry leaders, investors, and innovators from across academia and industry. It is a fantastic opportunity for us to showcase Prodessa Pharmaceuticals and present our innovative solution targeting the growing challenge of companion animal overweight and obesity.

We look forward to connecting with fellow innovators, investors and industry partners in Stockholm!

Learn more about the NLSDays here: https://nlsdays.com/ 

Following a highly productive week, the team at Prodessa Pharmaceuticals would like to extend our sincere gratitude to the organizers of DIAH 2026 for hosting an exceptional event!!

The conference brought together the brightest minds in animal health, offering a vital platform to discuss the industry's most pressing challenges and exciting advancements. For us, it was an invaluable opportunity to learn more about the veterinary industry and to share our vision for transforming the weight management market for companion animals.  

We want to thank all the participants, and partners who took the time to meet with us. The high-calibre interactions, collaborative spirit, and shared insights have given us tremendous momentum as we continue developing our pipeline. We look forward to building on the relationships forged this week and working together to elevate the standard of care for pets globally.

Missed us at the event? We would still love to connect. Visit our contact page or follow our corporate LinkedIn page to get in touch.

We are delighted to have been selected to give a presentation in the Emerging Start-Up Pitch Session at the DIAH – Discovery to Innovation in Animal Health Conference, taking place 19–21 May 2026 in Bruges, Belgium. This conference connects the world of animal research from academia to industry.
This is a great opportunity for us to introduce Prodessa Pharmaceuticals and our  innovative solution for the growing challenge of overweight and obesity in companion animals.

Looking forward to meeting you all in Bruges.

More information on the conference can be found here https://www.diah-conference.com/